Gene expression analysis technology to accelerate enhancement of plants important in human and animal health, food production, renewable energy and other commercial applications
Agilent Technologies has announced that it will supply Orion Genomics with Agilent gene expression analysis technology to accelerate Orion's enhancement of plants important in human and animal health, food production, renewable energy and other commercial applications.
The technology includes a full suite of Agilent gene expression technologies, including recently released catalogue Arabidopsis microarrays, automated microarray scanner, and a microfluidic-based bioanalyser.
"The addition of Agilent gene expression technologies to Orion Genomics's research capabilities enables us to mine our proprietary, comprehensive gene sets to pinpoint genes responsible for specific traits of commercial interest.
We evaluated alternative gene expression technologies and found Agilent's quality unparalleled," said Nathan Lakey, president and CEO, Orion Genomics.
"Adding Agilent's technology to Orion's world-class database of plant genes offers us significant growth in our intellectual property portfolio, culminating in plants enhanced for human and animal health, and food and energy production." "Our relationship with Orion Genomics, a recognised leader in plant research, is most promising as it further extends Agilent's presence into this community. While we have long enjoyed a major market share in the emerging field of plant sciences, working with Orion will carry us to the next level," said John Jaskowiak, marketing manager of Agilent's Bio Research Unit.
